41 This finding was consistent with oral semaglutide, with mild-to-moderate gastrointestinal adverse events being the most commonly reported events in clinical trials
The starting dosage of semaglutide is 0.25 once weekly, while the tirzepatide dosage starts at 2.5 mg once weekly
EO: Validation, Investigation, Writing review & editing, Supervision, Methodology, Software, Funding acquisition, Resources, Project administration
Some plans might be more likely to cover a different medication called Zepbound for weight loss instead of Mounjaro
Of note, Ozempic is now approved in a higher 2 mg dose, and effectiveness compared to Mounjaro with this higher dose may vary
has also received support from the National Institutes of Health (NIH 2R44DK127580, NIH 1R01CA249807) and California Institute of Regenerative Medicine (CIRM DISC2-13205)